查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1262024

適體市場-全球行業規模、份額、趨勢、機會和預測，2018-2028 按類型、技術、應用、最終用戶、地區和競爭分析

Aptamers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type, By Technology, By Application, By End user, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在 2024 年至 2028 年的預測期內，全球適體市場預計將以穩定的複合年增長率增長。 這可能是由於製藥和生物技術行業增加了對研發的投資。 此外，預計在預測期內，對高效和低成本適配體的需求不斷增長將帶來利潤豐厚的增長。 同樣，用於治療罕見疾病的新型療法的持續開發也將推動適體市場的長期增長。 同樣，人們越來越意識到適體相對於抗體的優勢，例如熱穩定性、減少生產時間和具有成本效益的合成，將進一步推動市場增長。 此外，適體可以針對更廣泛的分子，這進一步推動了全球適體市場的增長。 近年來，越來越多的新適體獲得批准也是推動市場增長的主要因素之一。

在工業中的使用增加

多年來，適體已成功用於病原體識別、癌症識別和環境污染監測。 此外，適體也被用作幹細胞標記物。 環境污染意識的增強和減少環境污染的需求預計將支持全球適體市場的增長。 此外，癌症、心血管疾病、神經退行性疾□□病和獲得性免疫缺陷綜合症等危及生命的疾病日益流行是推動對基於適體療法的新型有效檢測方法需求的主要因素。預計將進一步推動增長預測期內的市場。 根據世界癌症觀察站的數據，2020 年全球將報告約 19,292,789 例新癌症病例，其中乳腺癌、肺癌、結腸癌、前列腺癌和胃癌是最常見的類型。 由於適配體在癌症意識中的使用越來越多，以及為開發各種治療方法而進行的臨床試驗數量不斷增加，預計未來幾年對適配體的需求將會增長。 預計在預測期內，為改進診斷設備和藥物及其載體而進行的不斷增加的研發活動也將增加對適體市場的需求。 此外，民間組織正在與學術機構和研究機構合作開發下一代產品並擴大市場。 同樣，食品和飲料行業應用的增加預計將在預測期內推動市場增長。

適體意識的增強

多年來，適體在各行各業的使用不斷增加以及與適體相關的技術創新推動了市場的增長。 適體也是單鏈 DNA 或 RNA 分子，可以選擇性地結合特定靶標，與單克隆抗體相比具有許多優勢，預計到 2028 年將推動市場增長。 這些分子結合蛋白質、□、小分子、毒素、碳水化合物甚至活細胞等靶標。 它們可以通過從大型隨機序列池中進行選擇的過程生成，並且可以用於臨床和研究目的。

慢性病和罕見病患病率上升

罕見疾病的日益流行需要具有先進特定功能的新療法來對抗病毒，預計這將在預測期內推動對適體的需求。 同樣，技術的不斷進步有望推動市場的增長。 根據 2022 年 4 月發表在 Electrochimica Acta Journal 上的美國醫療保健機構的一項調查結果，適體具有診斷、藥物輸送、治療劑和藥物分析等多種用途，有望用作仿生分子識別元素，竟然在醫學界備受矚目。 此外，用於檢測癌症和其他疾病的新試劑盒的開發將在預測期內增加對適體的需求。

近期發展

  • 2021 年 3 月，Optimer 試劑的開發商 Aptamer Group 宣布與 Mologic 合併，Mologic 是側流和快速診斷檢測試劑盒的製造商。 進行合併的目的是生產新型冠狀病毒 SARS-CoV-2 的檢測試劑盒。
  • 2020 年 5 月，Portage Biotech 在獲得概念驗證後對 Saugatuck 療法進行了追加投資。 這啟動了下一筆 700,000 美元的注資。 Saugatuck 已經表明，其專有的 PD1 適體可以配製成 NLG 製劑，並且該製劑可以適當地調節 PD1 信號。

可自定義

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢

第 4 章 VOC（客戶之聲）

第五章適體全球市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（DNA 適體、XNA 適體、RNA 適體）
    • 通過技術（SELEX、其他）
    • 按應用（治療藥物開發、R&D、診斷藥物等）
    • 最終用戶（製藥公司、生物技術公司、學術/研究機構、合同研究機構等）
    • 按地區（北美、歐洲、亞太地區、南美、中東/非洲）
    • 按公司分類（2022 年）
  • 市場地圖
    • 按類型
    • 按技術
    • 通過申請
    • 最終用戶
    • 按地區

第六章北美適體市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按技術
    • 通過申請
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲適體市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按技術
    • 通過申請
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第八章亞太適體市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按技術
    • 通過申請
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9章南美適體市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按技術
    • 通過申請
    • 最終用戶
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲適體市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按技術
    • 通過申請
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 南非適體
    • 沙特阿拉伯適體
    • 阿聯酋適體

第 11 章市場動態

  • 司機
  • 做

第12章市場趨勢與發展

  • 近期發展狀況
  • 併購
  • 產品發布

第 13 章全球適體市場：SWOT 分析

第 14 章波特的五力分析

  • 行業競爭
  • 新進入的可能性
  • 供應商的力量
  • 客戶力量
  • 替代品的威脅

第15章競爭格局

  • 業務概覽
  • 提供的產品
  • 近期發展狀況
  • 財務（據報導）
  • 主要人物
  • SWOT 分析
    • Aptamer Group
    • Raptamer Discovery Group
    • Somalogic Inc.
    • Aptamer Sciences, Inc.
    • Aptagen LLC.
    • Maravai Lifesciences.
    • Kaneka Corporation.
    • Neoventures Biotechnology Inc.
    • Aptus Biotech.
    • Base Pair Biotechnologies.

第 16 章戰略建議

簡介目錄
Product Code: 14633

Global Aptamers market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing investments in the research and development sector by the pharmaceutical and biotechnology industries. Also, the growing demand for high-efficiency and low-cost aptamers is expected to create lucrative growth during the forecasted period. Similarly, the growing development of novel therapies for the treatment of rare diseases will drive the growth of the aptamers market over the years. Similarly, rising awareness of the advantages of aptamers, such as their thermal stability, shorter production time, and cost-effective synthesis, among others, over antibodies will further boost the growth of the market. Additionally, aptamers can target a wider spectrum of molecules, which further drives the growth of the global aptamer market. Increasing approvals of novel aptamers are also one of the major factors driving the growth of the market over the last few years.

Increasing Use Across Industries

Aptamers have been successfully used over the years for pathogen recognition, cancer recognition, and monitoring environmental contamination, among others. Additionally, aptamers are also used as stem cell markers. The growing awareness about environmental pollution and the need to reduce environmental contamination is expected to support the growth of the global aptamers market. Besides, the increasing prevalence of life-threatening diseases such as cancer, cardiovascular diseases, neurodegenerative diseases, and acquired immunodeficiency syndrome are the major factors enhancing the demand for new and effective detection assays based on aptamer therapy which will further boost the growth of the market during the forecasted period. According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer, and Stomach Cancer being the most prevalent types. The increasing use of aptamers in cancer recognition and the increasing number of clinical trials being conducted for the development of different treatments are expected to increase the demand for aptamers in the coming years. Also, growing research and development activities for improving diagnostic devices and drugs and their carriers will enhance the demand for the aptamers market in the forecasted period. Also, private organizations are collaborating with academic institutes and research laboratories to develop next-generation products and expand their market. Similarly, growing application in the food and beverage industry is anticipated to boost the growth of the market in the forecasted period.

Growing Awareness About Aptamers

The growing usage of aptamers by different industries and innovations happening related to aptamers has encouraged market growth over the years. Also, growing awareness among the industries about various benefits associated with aptamers, such as they are single-stranded DNA and RNA molecules that can selectively bind to a specific target and have numerous advantages over monoclonal antibodies, is expected to spur the market growth through 2028. These molecules bind with targets, including proteins, peptides, small molecules, toxins, carbohydrates, and even live cells. It can be created by a selection process from a large random sequence pool, and it can be used for both clinical and research purposes.

Growing Prevalence of Chronic and Rare Diseases

The growing prevalence of rare diseases requires new treatments with advanced characteristic features to fight against the viruses, which will enhance the demand for aptamers during the forecasted period. Similarly, continuous advancements in technologies are expected to drive the growth of the market. According to a research study by US Healthcare Agency published in Electrochimica Acta Journal in April 2022, the study results found that aptamers have come into the spotlight as bio-mimetic molecular recognition elements in the field of biomedicine due to various applications in diagnostics, drug delivery, therapeutics, and pharmaceutical analysis. Also, the development of new kits to detect cancer and other diseases increases the demand for aptamers in the forecasted period.

Market Segmentation

Global Aptamers market can be segmented by type, technology, application, end user, and by region. Based on type, the market can be segmented into DNA Aptamers, XNA Aptamers, and RNA Aptamers. Based on Technology, the market can be divided into SELEX, and Others. Based on application, the market can be differentiated into therapeutics development, research & development, diagnostics, and others. Based on end-user, the market can be grouped into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations, and others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America.

Recent Developments

  • In March 2021, Aptamer Group, the developer of Optimer reagents, announced its merger with Mologic, which is a manufacturer of lateral flow and rapid diagnostic test kits. The merger was executed with an aim to manufacture testing kits for Novel Coronavirus, i.e., SARS-CoV-2.
  • In May 2020, Portage Biotech made an additional investment in Saugatuck therapeutics after achieving proof of concept. This has triggered the next tranche of capital infusion of USD700,000. Saugatuck has been able to formulate a proprietary PD1 aptamer in the NLG formulation and has shown the formulation properly modulates PD1 signaling.

Market Players

Aptamer Group., Raptamer Discovery Group., Somalogic Inc., Aptamer Sciences, Inc., Aptagen LLC., Maravai Lifesciences., Kaneka Corporation., Neoventures Biotechnology Inc., and Aptus Biotech., Base Pair Biotechnologies. are some of the leading players operating in the Global Aptamers Market.

Report Scope

In this report, the Global Aptamers market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Aptamers Market, By Type:

  • DNA Aptamers
  • XNA Aptamers
  • RNA Aptamers

Aptamers Market, By Technology:

  • SELEX
  • Others

Aptamers Market, By Application:

  • Therapeutics Development
  • Research & development
  • Diagnostics
  • Others

Aptamers Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Contract Research Organizations
  • Others

Aptamers Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aptamers Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Aptamers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (DNA Aptamers, XNA Aptamers, RNA Aptamers)
    • 5.2.2. By Technology (SELEX, Others)
    • 5.2.3. By Application (Therapeutics Development, Research & Development, Diagnostics, Others)
    • 5.2.4. By End user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Others)
    • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.6. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Type
    • 5.3.2 By Technology
    • 5.3.3 By Application
    • 5.3.4 By End user
    • 5.3.5 By Region

6. North America Aptamers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End user
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Aptamers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Aptamers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Aptamers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Aptamers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End user
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Aptamers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany Aptamers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Aptamers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Aptamers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Aptamers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Aptamers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End user
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Aptamers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Aptamers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Aptamers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Aptamers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Aptamers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Aptamers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End user
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Aptamers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Aptamers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Aptamers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Aptamers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End user
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Aptamers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Aptamers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Aptamers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Aptamers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Aptamer Group
    • 15.6.2 Raptamer Discovery Group
    • 15.6.3 Somalogic Inc.
    • 15.6.4 Aptamer Sciences, Inc.
    • 15.6.5 Aptagen LLC.
    • 15.6.6 Maravai Lifesciences.
    • 15.6.7 Kaneka Corporation.
    • 15.6.8 Neoventures Biotechnology Inc.
    • 15.6.9 Aptus Biotech.
    • 15.6.10 Base Pair Biotechnologies.

16. Strategic Recommendations